Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Director departure
Appointed director
|
|
BIONOVO INC (BNVI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2012 |
8-K
| Form 8-K - Current report |
| 04/17/2008 |
8-K
| Appointed a new director|
Docs:
|
"John D. Baxter, M.D. Joins Bionovo's Board of Directors EMERYVILLE, Calif., April 17 – Bionovo, Inc. announced today the appointment of John D. Baxter, M.D., to the company’s Board of Directors. Dr. Baxter has extensive experience in academic research as well as with pharmaceutical and biotech companies, and in particular in advancing endocrine drugs. “We are very excited to have John on board as we are advancing our clinical trial programs,” said Isaac Cohen, O.M.D., Bionovo’s Chairman and CEO. He added, “John is a pioneer in endocrine research as well as one of the first to bridge the academic and industrial relationship, transforming his major discoveries in science into therapies. John’s work in endocrinology and his experience with Wall Street make him a perfect fit with our platform ..." |
|
| 06/12/2007 |
8-K
| Resignation/termination of a director, Appointed a new director |
| 05/01/2007 |
8-K
| Appointed a new director |
| 04/13/2006 |
8-K
| Appointed a new director |
| 03/20/2006 |
8-K
| Appointed a new director |
|
|